340 related articles for article (PubMed ID: 18608583)
1. Challenges in the development of magnetic particles for therapeutic applications.
Barry SE
Int J Hyperthermia; 2008 Sep; 24(6):451-66. PubMed ID: 18608583
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
3. Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia.
Fortin JP; Wilhelm C; Servais J; Ménager C; Bacri JC; Gazeau F
J Am Chem Soc; 2007 Mar; 129(9):2628-35. PubMed ID: 17266310
[TBL] [Abstract][Full Text] [Related]
4. Medical application of functionalized magnetic nanoparticles.
Ito A; Shinkai M; Honda H; Kobayashi T
J Biosci Bioeng; 2005 Jul; 100(1):1-11. PubMed ID: 16233845
[TBL] [Abstract][Full Text] [Related]
5. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer.
Ivkov R; DeNardo SJ; Daum W; Foreman AR; Goldstein RC; Nemkov VS; DeNardo GL
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7093s-7103s. PubMed ID: 16203808
[TBL] [Abstract][Full Text] [Related]
6. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
7. Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
Taboada E; Rodríguez E; Roig A; Oró J; Roch A; Muller RN
Langmuir; 2007 Apr; 23(8):4583-8. PubMed ID: 17355158
[TBL] [Abstract][Full Text] [Related]
8. MRI measurement of regional lung deposition in mice exposed nose-only to nebulized superparamagnetic iron oxide nanoparticles.
Martin AR; Thompson RB; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):335-42. PubMed ID: 18800881
[TBL] [Abstract][Full Text] [Related]
9. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes.
Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH
Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733
[TBL] [Abstract][Full Text] [Related]
10. Magnetic iron oxide nanoparticles for biomedical applications.
Laurent S; Bridot JL; Elst LV; Muller RN
Future Med Chem; 2010 Mar; 2(3):427-49. PubMed ID: 21426176
[TBL] [Abstract][Full Text] [Related]
11. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications.
Kettering M; Zorn H; Bremer-Streck S; Oehring H; Zeisberger M; Bergemann C; Hergt R; Halbhuber KJ; Kaiser WA; Hilger I
Phys Med Biol; 2009 Sep; 54(17):5109-21. PubMed ID: 19661569
[TBL] [Abstract][Full Text] [Related]
12. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
[TBL] [Abstract][Full Text] [Related]
13. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors.
Larsen EK; Nielsen T; Wittenborn T; Rydtoft LM; Lokanathan AR; Hansen L; Østergaard L; Kingshott P; Howard KA; Besenbacher F; Nielsen NC; Kjems J
Nanoscale; 2012 Apr; 4(7):2352-61. PubMed ID: 22395568
[TBL] [Abstract][Full Text] [Related]
15. Cellular magnetic resonance imaging using superparamagnetic anionic iron oxide nanoparticles: applications to in vivo trafficking of lymphocytes and cell-based anticancer therapy.
Smirnov P
Methods Mol Biol; 2009; 512():333-53. PubMed ID: 19347287
[TBL] [Abstract][Full Text] [Related]
16. Magnetic microspheres and tissue model studies for therapeutic applications.
Ramachandran N; Mazuruk K
Ann N Y Acad Sci; 2004 Nov; 1027():99-109. PubMed ID: 15644349
[TBL] [Abstract][Full Text] [Related]
17. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
18. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
19. Digital microfluidics and delivery of molecular payloads with magnetic porous silicon chaperones.
Dorvee JR; Sailor MJ; Miskelly GM
Dalton Trans; 2008 Feb; (6):721-30. PubMed ID: 18239825
[TBL] [Abstract][Full Text] [Related]
20. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
